
News
Tempus AI pre-market surged over 5% as the company received FDA 510(K) clearance for its RNA NGS in vitro diagnostic device Tempus Xr Ivd

Tempus AI pre-market surged over 5% as the company received FDA 510(K) clearance for its RNA NGS in vitro diagnostic device Tempus Xr Ivd